Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/850
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wootten, Addie | - |
dc.date.accessioned | 2016-11-07T05:02:11Z | - |
dc.date.available | 2016-11-07T05:02:11Z | - |
dc.date.issued | 2015-07 | - |
dc.identifier.citation | (2015), Invited Presentations and Oral Abstracts. Asia-Pac J Clin Oncol, 11: 22–32. | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/850 | - |
dc.description.abstract | In recent years there has been emerging interest in alternative management strategies designed to reduce the morbidity of treatment for low risk localised prostate cancer. Active surveillance (AS) protocols for the close observation and management of men with low risk localised prostate cancer have emerged in the clinical and research literature as a viable and safe option in managing these men, potentially avoiding, or at least delaying, radical treatment. However, the decision to actively monitor, rather than actively treat cancer can be challenging for patients, as it contradicts commonly held beliefs that cancer requires immediate and radical treatment, and there is growing awareness that AS could be associated with heightened levels of patient anxiety. Qualitative research has identified that men do experience uncertainty, worry and fear about cancer progression, PSA and biopsy testing. Furthermore, there have been some studies that have reported that anxiety may be a contributing factor in patient choice to cease AS and engage in active radical treatment for their prostate cancer. It has been reported that as many as 45% of men opt for active radical treatment without experiencing clinical signs of disease progression or other clinical indication to do so. With this comes the need for a significant change in patient expectations and understanding of low risk localised prostate cancer and there are important psychological considerations that need to be made when counselling men to consider AS as a management approach to their prostate cancer. | en_US |
dc.subject | Prostate Cancer | en_US |
dc.subject | Low Risk Localised Prostate Cancer | en_US |
dc.subject | Active Surveillance | en_US |
dc.subject | Psychology | en_US |
dc.subject | Patient Anxiety | en_US |
dc.subject | Cancer Growth | en_US |
dc.subject | Qualitative Research | en_US |
dc.subject | Disease Progression | en_US |
dc.subject | Cancer Management | en_US |
dc.subject | Counselling | en_US |
dc.subject | Psychological Considerations | en_US |
dc.subject | Australian Prostate Cancer Research Centre Epworth | en_US |
dc.subject | Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia | en_US |
dc.subject | UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia | en_US |
dc.title | The psychology of active surveillance: learning to live with an untreated cancer. | en_US |
dc.type | Conference Paper | en_US |
dc.identifier.doi | 10.1111/ajco.12376 | en_US |
dc.description.conferencename | 6th Annual Scientific Meeting of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Redefining Personalised Medicine. | en_US |
dc.description.conferencelocation | Sydney, NSW, Australia | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cancer Services Epworth Prostate Centre Mental Health UroRenal, Vascular |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.